NIH-funded research R01 grant

Azithromycin adjunct in kids with severe malnutrition in Africa

Official title: Azithromycin as adjunctive treatment for uncomplicated severe acute malnutrition: the AMOUR trial

Funded at Washington University · NIH-11578609 · Data updated 2026-11-12

A randomized trial will compare azithromycin, amoxicillin, and placebo as adjunctive antibiotics for children with uncomplicated severe acute malnutrition to see which supports better weight gain and recovery.

More Malnutrition research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startDecember 8, 2023
Project endNovember 30, 2028
Funding year2026
Award (this year)$118,828
NIH project number7R01HD111532-04
Project IDNIH-11578609 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children aged roughly 0–11 years with uncomplicated severe acute malnutrition in the study region, with active follow-up planned.

Less likely to help

Some children may not experience additional benefit from antibiotic adjuncts and could experience side effects or antibiotic exposure without improvement.

What this research studies

This trial involves young children with uncomplicated severe acute malnutrition in sub-Saharan Africa. They will be randomly assigned to receive azithromycin, amoxicillin, or placebo alongside standard care, and followed to measure weight gain, nutritional recovery, and effects on the gut microbiome. The study builds on previous findings that antibiotics can influence outcomes in malnutrition and may identify a superior option for this population. Enrollment appears feasible based on pilot data showing rapid recruitment, and the study aims to clarify whether a broader-spectrum or a targeted antibiotic provides the most benefit. Results could inform guidelines for antibiotic use in SAM and potentially improve child survival and health.

Why it matters

Potential benefit: If successful, the trial could identify an antibiotic treatment strategy that improves nutritional recovery and growth for children with uncomplicated SAM.

How similar studies have gone: Prior trials have shown mixed results for antibiotics in uncomplicated SAM, with equipoise supporting a definitive comparison among options in this study.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Oldenburg, Catherine Elizabeth — Washington University
  • Study coordinator: Oldenburg, Catherine Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.